Armistice Capital
Armistice is a venture capital firm that focuses on investing in health care and consumer sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Armistice Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$325M
Social
Crunchbase
Metrics
4,439,499Website Global Rank
2,210Website Monthly Traffic
Twitter Followers
Description
Armistice is a venture capital firm that focuses on investing in health care and consumer sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2022 | Karyopharm Therapeutics | Post-IPO Equity | 0 |
| 3/2022 | 2seventy bio | Post-IPO Equity | 0 |
| 6/2014 | Medigus | Post-IPO Equity | 11.1M |
| 5/2023 | Lyra Therapeutics | Post-IPO Equity | 0 |
| 2/2023 | Spruce Biosciences | Post-IPO Equity | 0 |
| 1/2021 | Kiora Pharmaceuticals | Post-IPO Equity | 8M |
| 11/2022 | Abeona Therapeutics | Post-IPO Equity | 0 |
| 3/2022 | Eyenovia | Post-IPO Equity | 15M |
| 7/2022 | Provention Bio | Post-IPO Equity | 60M |
| 10/2022 | immatics biotechnologies | Post-IPO Equity | 0 |
| 8/2013 | Addex Therapeutics | Post-IPO Equity | 3.5M |
| 12/2021 | erytech | Post-IPO Equity | 7.8M |
| 9/2021 | Mauna Kea Technologies | Post-IPO Equity | 14.7M |
| 1/2022 | Xeris Pharmaceuticals | Post-IPO Equity | 30M |
| 7/2022 | Provention Bio | Post-IPO Equity | 0 |
| 3/2022 | 2seventy bio | Post-IPO Equity | 0 |
| 3/2022 | Eyenovia | Post-IPO Equity | 0 |
| 1/2022 | Xeris Pharmaceuticals | Post-IPO Equity | 0 |
| 12/2021 | erytech | Post-IPO Equity | 0 |
| 9/2021 | Mauna Kea Technologies | Post-IPO Equity | 0 |
| 1/2021 | Kiora Pharmaceuticals | Post-IPO Equity | 0 |
| 6/2014 | Medigus | Post-IPO Equity | 0 |
| 8/2013 | Addex Therapeutics | Post-IPO Equity | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
